##
|||||Page||
|---|---|---|---|---|---|
|Reference|and Administrative
Details|||||
|Report of|the Trustees||2|to|3|
|Report of|the Independent
Auditors||4|to|6|
|Statement|of Financial|Activities||||
|Balance Sheet||||||
|Notes to the Financial||Statements|9|to|14|
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|||||Sta ement|Sta ement|Sta ement|of Financia|Activi ies|||
|---|---|---|---|---|---|---|---|---|---|---|
|||||for|the|ear|ended 31 March 2022||||
||||||||||2022|2021|
||||||||||Unrestricted||
||||||||||fund|Total funds|
||||||Notes||||E|E|
|Income and endowments||from|||||||||
|Charitable|activities||||||||||
|Autism
diagnostic assessment|||services||||||46,600|46,150|
|Expenditure|on||||||||||
|Charitable|activities||||||||||
|Autism
diagnostic assessment|||services||||||62,346|50,687|
|NET INCOME/(EXPENDITURE)|||||||||(6,746)|(4,537)|
|Reconciliation
offunds|||||||||||
|Total funds|brought
forward||||||||23,023|27,560|
|Total funds|carried forward||||||||16,278|23,023|
|Continuing
All income|operations
and expenditure|has arisen||from continuing|||activities.||||
|The Statement
of Financial||Activities||includes|all|gains|and losses recognised||in the year.||
##
|||||SPARC AUTISM|||
|---|---|---|---|---|---|---|
|||||Balance Sheet|||
|||||31 March 2022|||
||||||2022|2021|
||||||Unrestricted||
||||||fund|Total funds|
|||||Notes|f:||
|Current|assets||||||
|Debtors|||||21,749|43,982|
|Cash at bank|||||13,147|12,346|
||||||34,896|56,328|
|Creditors|||||||
|Amounts|falling due within||one year|10|(18,618)|(33,305)|
|Net current||assets|||16,278|23,023|
|Total assets||less current|liabilities||16,278|23,023|
|NET ASSETS/(LIABILITIES)|||||16,278|23,023|
|Funds|||||||
|Unrestricted||funds|||16,278|23,023|
|Total funds|||||16,278|23,023|
##
##
##
##
##
##
##
##
##
##
||||||||||||||2022|2021|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||Activity||||||E|E|
||Assessment|||income|||Autism|diagnostic assessment|||services||46,8OO|46,150|
|3.|Charitable||activities costs||||||||||||
||||||||||||Direct||Support||
||||||||||||Costs (see||costs (see||
||||||||||||note 4)||note 6)|Totals|
|||||||||||||E|E|E|
||Autism
diagnostic assessment||||||services||||28,090||24,266|52,346|
|4.|Direct costs|||of charitable||activities|||||||||
||||||||||||||2022|2021|
||||||||||||||E|E|
||Clinician|fees|||||||||||28,090|26,620|
|6.|Support|costs|||||||||||||
||||||||||||||Governance||
||||||||Management|||Finance|Other||costs|Totals|
||||||||||E|E||E|E|E|
||Autism
diagnostic||||||||||||||
||assessment|||services|||20,288||||2,278||1,660|24,266|
||Support|costs, included|||in the||above, are||as follows:||||||
||||||||||||||2022|2021|
||||||||||||||Autism||
||||||||||||||diagnostic||
||||||||||||||assessment|Total|
||||||||||||||services|activities|
||||||||||||||E|E|
||Office and administration||||||||||||20,288|20,304|
||Bank charges||||||||||||129|98|
||Insurance||||||||||||2,278|2,225|
||Auditors'|remuneration|||||||||||1,660|1,440|
||||||||||||||24,256|24,067|
##
##
|Net inco|me/(expenditure)
is stated after charging/(crediti|ng):||
|---|---|---|---|
|||2022|2021|
|||6||
|Auditors'|remuneration|1,660|1,440|
##
##
||During
the period the company
the course of normal
charitable|incurred
clinic
activities.|incurred
clinic
activities.|incurred
clinic
activities.|al fees t|otalling
anil (2021 - Enil) which were payab|le to trustees
in|
|---|---|---|---|---|---|---|---|
||At the year-end
anil (2021-anil)|was owed to|||trustees|in respect of clinician fees payable.||
||Comparatives
for the statement||of financial||activities||Unrestricted|
||||||||fund|
||Income and endowments
from|||||||
||Charitable
activities
Autism
diagnostic assessment|services|||||46,150|
||Expenditure
on|||||||
||Charitable
activities
Autism
diagnostic assessment|services|||||50,687|
||NET INCOME/(EXPENDITURE)||||||(4,537)|
||Reconciliation
of funds|||||||
||Total funds brought
forward||||||27,560|
||Total funds carried forward||||||23,023|
|9.|Debtors: amounts
falling
due within|||one year||2022|2021|
||Trade debtors
Prepayments
and accrued income|||||20,676
1,074|43,425
557|
|||||||21,?49|43,982|
##
|10.|Credito|rs:|a|m|ounts
f|alling due|within
one year||||
|---|---|---|---|---|---|---|---|---|---|---|
||||||||||2022|2021|
||||||||||E|E|
||Trade creditors
Accruals
and deferred|||||income|||17,218
1,400|31,965
1,340|
||||||||||18,618|33,305|
|11.|Movement||in funds||||||||
||||||||||Net||
||||||||||movement||
|||||||||At 1/4/21|in funds|At 31/3/22|
|||||||||E|E||
||Unrestricted|||funds|||||||
||General|fund||||||23,023|(6,745)|16,278|
||TOTAL|FUNDS||||||23,023|(6,745)|16,278|
||Net movement||||in funds,|included|in the above are as follows:||||
|||||||||Incoming|Resources|Movement|
|||||||||resources|expended|in funds|
|||||||||E|E||
||Unrestricted|||funds|||||||
||General|fund||||||45,600|(52,345)|(6,745)|
||TOTAL FUNDS|||||||45,600|(52,345)|(6,745)|
##
|||||||Net||
|---|---|---|---|---|---|---|---|
|||||||movement||
||||||At 1/4/20|in funds|At 31/3/21|
||||||E|E|E|
|Unrestricted||funds||||||
|General|fund||||27,560|(4,537)|23,023|
|TOTAL|FUNDS||||27,560|(4,537)|23,023|
|Comparative||net movement|in funds,|Included|in the above are as follows:|||
||||||Incoming|Resources|Movement|
||||||resources|expended|in funds|
||||||E|E|E|
|Unrestricted||funds||||||
|General|fund||||46,150|(50,687)|(4,537)|
|TOTAL|FUNDS||||46,150|(50,687)|(4,537)|
##
##
##
|A current|year|12 months
and prior year 12|months
combined
position|is as fol|ows;||
|---|---|---|---|---|---|---|
||||||Net||
||||||movement||
||||At|1/4/20|in funds|At 31/3/22|
|||||E|||
|Unrestricted
General
fund||funds||27,560|(11,282)|16,278|
|TOTAL|FUN|S||27,560|(11,282)|16,278|
##
||||Incoming|Resources|INovement|
|---|---|---|---|---|---|
||||resources|expended|in funds|
||||E|E||
|Unrestricted
General
fund||funds|91,750|(103,032)|(11,282)|
|TOTAL|FUNDS||91,750|(103,032)|(11,282)|
##
##
##
##